Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US14779347Application Date: 2014-03-27
-
Publication No.: US09637483B2Publication Date: 2017-05-02
- Inventor: Masato Yoshida , Hiroyuki Nagamiya , Yusuke Ohba , Masaki Seto , Takatoshi Yogo , Satoshi Sasaki , Norihito Tokunaga , Kazuyoshi Aso
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2013-070477 20130328
- International Application: PCT/JP2014/058999 WO 20140327
- International Announcement: WO2014/157569 WO 20141002
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D401/14 ; C07D471/04 ; C07D519/00

Abstract:
Provided is a compound or a salt thereof, which has an excellent JAK inhibitory action, and is useful as a prophylactic or therapeutic agent for autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's syndrome, multiple sclerosis, systemic lupus erythematosus, etc.), cancer (leukemia, uterine leiomyosarcoma, prostate cancer, multiple myeloma, cachexia, myelofibrosis, etc.) and the like. The present invention relates to a compound represented by the formula (I) wherein each symbol is as defined in the present specification, or a salt thereof.
Public/Granted literature
- US20160039811A1 HETEROCYCLIC COMPOUND Public/Granted day:2016-02-11
Information query
IPC分类: